Ajanta Pharma Q2 FY27 Results: Consolidated Net Profit ₹388 Crore on Total Income of ₹1,832 Crore
Ajanta Pharma (AJANTPHARM on NSE) said in a filing on 30 Oct 2026 that consolidated total income for the quarter ended 30 Sep 2026 was ₹1,831.55 crore and profit after tax was ₹388 crore. Standalone total income was ₹1,777.69 crore and net profit was ₹379.89 crore.
- Earnings
- specialty pharmaceuticals